The Hebrew University of Jerusalem, Faculty of medicine, the Hebrew University and Hadassah Braun School of Public health and Community Medicine, Jerusalem, Israel.
Jerusalem District Health Office, Ministry of Health, Jerusalem, Israel.
Euro Surveill. 2019 Feb;24(6). doi: 10.2807/1560-7917.ES.2019.24.6.1800004.
BackgroundChildhood vaccination schedules recommend vaccine doses at predefined ages.AimWe evaluated vaccination completeness and timeliness in Jerusalem, a district with recurrent vaccine-preventable disease outbreaks.MethodsVaccination coverage was monitored by the up-to-date method (vaccination completeness at age 2 years). Timeliness of vaccination was assessed in children (n = 3,098, born in 2009, followed to age 48 months, re-evaluated at age 7 years) by the age-appropriate method (vaccine dose timeliness according to recommended schedule). Vaccines included: hepatitis B (HBV: birth, 1 month and 6 months); diphtheria, tetanus, acellular pertussis, polio, b (DTaP-IPV-Hib: 2, 4, 6 and 12 months); pneumococcal conjugate (PCV: 2, 4 and 12 months); measles-mumps-rubella/measles-mumps-rubella-varicella (MMR/MMRV: 12 months) and hepatitis A (HAV: 18 and 24 months).ResultsOverall vaccination coverage (2014 cohort evaluated at age 2 years) was 95% and 86% for MMR/MMRV and DTaP-IPV-Hib4, respectively. Most children (94%, 91%, 79%, 95%, 92% and 82%) were up-to-date for HBV3, DTaP-IPV-Hib4, PCV3, MMR/MMRV1, HAV1 and HAV2 vaccines at 48 months, but only 32%, 28%, 38%, 58%, 49% and 20% were vaccinated timely (age-appropriate). At age 7 years, the median increase in vaccination coverage was 2.4%. Vaccination delay was associated with: high birth order, ethnicity (higher among Jews vs Arabs), birth in winter, delayed acceptance of first dose of DTaP-IPV-Hib and multiple-dose vaccines (vs MMR/MMRV). Jewish ultra-Orthodox communities had low vaccination coverage.ConclusionsConsiderable vaccination delay should be addressed within the vaccine hesitancy spectrum. Delays may induce susceptibility to vaccine-preventable disease outbreaks; tailored programmes to improve timeliness are required.
背景
儿童免疫接种计划推荐在预定义的年龄接种疫苗剂量。
目的
我们评估了耶路撒冷的疫苗接种完成情况和及时性,耶路撒冷是一个反复发生疫苗可预防疾病暴发的地区。
方法
通过最新方法(2 岁时的疫苗接种完成情况)监测疫苗接种覆盖率。通过适龄方法(根据推荐时间表评估疫苗剂量及时性)评估儿童(n=3098,出生于 2009 年,随访至 48 个月,7 岁时重新评估)的疫苗接种及时性。疫苗包括:乙型肝炎(HBV:出生时、1 个月和 6 个月);白喉、破伤风、无细胞百日咳、脊髓灰质炎、b 型(DTaP-IPV-Hib:2、4、6 和 12 个月);肺炎球菌结合疫苗(PCV:2、4 和 12 个月);麻疹-腮腺炎-风疹/麻疹-腮腺炎-风疹-水痘(MMR/MMRV:12 个月)和甲型肝炎(HAV:18 和 24 个月)。
结果
总体疫苗接种覆盖率(2014 年队列在 2 岁时评估)分别为 MMR/MMRV 和 DTaP-IPV-Hib4 的 95%和 86%。大多数儿童(94%、91%、79%、95%、92%和 82%)在 48 个月时已完成 HBV3、DTaP-IPV-Hib4、PCV3、MMR/MMRV1、HAV1 和 HAV2 疫苗的接种,但仅有 32%、28%、38%、58%、49%和 20%及时接种(适龄)。7 岁时,疫苗接种覆盖率中位数增加了 2.4%。疫苗接种延迟与以下因素有关:高出生顺序、种族(犹太人高于阿拉伯人)、冬季出生、延迟接受第一剂 DTaP-IPV-Hib 和多剂量疫苗(与 MMR/MMRV 相比)。犹太极端正统派社区的疫苗接种覆盖率较低。
结论
在疫苗犹豫范围内,应解决相当大的疫苗接种延迟问题。延迟可能会导致对疫苗可预防疾病暴发的易感性;需要制定改善及时性的定制计划。